Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Atrophy × Rabeprazole × Gastrointestinal × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5 Non-Erosive Reflux Disease 1 Helicobacter Infections 1 Gastrointestinal Hemorrhage 1 Gastroesophageal Reflux 1 Gastritis, Atrophic 1 Dyspepsia 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Barrett Esophagus 1 Atrophy 1 Adenocarcinoma 1

Interventions

Rabeprazole 1 Proton Pump Inhibitors 1 Omeprazole 1 Clarithromycin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting

Gastrointestinal

Atrophy, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡